Find more information about Teva in your location, or contact a local representative on our local sites
North America
International Markets
North America
Toggle North America
International Markets
Toggle International Markets
Europe
Toggle Europe
Evaluation of the Long-Term Effects of Rasagiline in Parkinson's Disease Subjects
- Study Title
- ADAGIO Follow Up Study: Evaluation of the Long-Term Effects of Rasagiline in Parkinson's Disease Subjects
- Teva Identifier
- TVP-1012/501 | 2009-011541-24
- ClinicalTrials.gov Identifier
- NCT00936676
- Study Status
- Completed
- Trial Condition(s)
- Parkinson's Disease
- Interventions
- Drug: rasagiline mesylate
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age Range
- Child, Adult, Older Adult
- Trial Duration
- 07/01/2009 - 03/01/2013
